Kevin Tymitz, MD
Surgery · Cincinnati, OHNPI 1477884633
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $19,672 of the $32,785 with a category attached, or 60.0%. 18 manufacturers reported payments, led by Johnson & Johnson at 51.7% of the total. Reporting peaked in 2019 at $13,840 and has fallen 94.9% since, to $703 in 2025. Among surgery clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 103 payments — averaging $318.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$17K
- Medical Device Business Services, Inc.$4K
- Intuitive Surgical$4K
- Covidien LP$3K
- Ethicon Endo-surgery Inc.$2K
- Stryker$648
- plus $2K from 12 others
Across 7 payments — averaging $5146.40 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Standard Bariatrics, Inc.$36K
What the payments were for
- Consulting fees$19,67260%
- Speaking & faculty fees$2,8009%
- Travel & lodging$6,15119%
- Food & beverage$2,8429%
- Education$1,3054%
- Gifts$150%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(2 entities) | 32 | $16,955 |
| Medical Device Business Services, Inc. | 4 | $4,333 |
| Intuitive Surgical | 21 | $4,246 |
| Covidien LP | 2 | $2,805 |
| Ethicon Endo-surgery Inc. | 1 | $1,575 |
| Stryker | 9 | $648 |
| Standard Bariatrics, Inc. | 1 | $500 |
| Boston Scientific | 3 | $487 |
| Arthrex | 8 | $384 |
| Legacy Ortho LLC | 2 | $284 |
| W. L. Gore & Associates, Inc. | 3 | $250 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $149 |
| Merck | 4 | $58 |
| Phathom Pharmaceuticals, Inc. | 2 | $32 |
| Apollo Endosurgery US Inc | 1 | $21 |
| Heron Therapeutics, Inc. | 1 | $21 |
| Innocoll Pharmaceuticals Limited | 1 | $18 |
| LSI Solutions Inc | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$32,785 in reported general payments places this provider in the 90th percentile of 988 surgery providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sucralfate | 31 | $4,573 |
| Ursodiol | 12 | $1,391 |
| Pantoprazole Sodium | 134 | $1,381 |
| Ondansetron Hcl | 60 | $879 |
| Ondansetron OdtOndansetron | 16 | $246 |
| Promethazine Hcl | 15 | $128 |
Paid to pharmacies, not to this prescriber.
Other surgery in Cincinnati
- Benjamin StiversCincinnati$66K
- Cory BarratCincinnati$46K
- Joseph ImbusCincinnati$39K
- Jonathan ThompsonWest Chester$2.1M
- Raymond OndersCleveland$1.2M
- Neilendu KunduCleveland$808K
- Michael MearaColumbus$808K
- Chase WehrleCleveland$741K
- Craig JarrettCleveland$622K
- Greg StarleyCuyahoga Falls$594K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.